Organovo Holdings, Inc. (ONVO) financial statements (2021 and earlier)

Company profile

Business Address 6275 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End March 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30364463625048
Cash and cash equivalents30364463625048
Receivables01110  
Inventory, net of allowances, customer advances and progress billings 011000
Inventory 011000
Deferred costs      0
Other undisclosed current assets0111111
Total current assets:31394765645149
Noncurrent Assets
Property, plant and equipment 234421
Restricted cash and investments000000 
Other noncurrent assets0000000
Other undisclosed noncurrent assets     00
Total noncurrent assets:0234421
TOTAL ASSETS:31415069685350
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2345362
Accounts payable1101110
Accrued liabilities2334221
Employee-related liabilities     21
Debt     00
Deferred rent credit 0
Derivative instruments and hedges, liabilities    000
Deferred revenue and credits11110
Contract with customer, liability1
Other liabilities     00
Other undisclosed current liabilities     (2)(1)
Total current liabilities:2456452
Noncurrent Liabilities
Long-term debt and lease obligation      0
Capital lease obligations     0
Liabilities, other than long-term debt 111100
Deferred revenue and credits11100
Deferred rent credit 1
Total noncurrent liabilities: 111100
Total liabilities:2457552
Stockholders' equity
Stockholders' equity attributable to parent, including:29364562624948
Common stock0000000
Additional paid in capital306297279262223171140
Accumulated other comprehensive loss  (0)(0)   
Accumulated deficit(277)(261)(234)(199)(161)  
Other undisclosed stockholders' equity attributable to parent  0  (122)(92)
Total stockholders' equity:29364562624948
TOTAL LIABILITIES AND EQUITY:31415069685350

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues3354110
Revenue, net43100
Cost of revenue(1)(1)(1)(1)  (0)
Cost of goods and services sold(0)(0)    (0)
Gross profit:2343110
Operating expenses(28)(30)(39)(42)(40)(31)(21)
Other undisclosed operating income00   00
Operating loss:(26)(27)(35)(39)(39)(30)(21)
Nonoperating income (expense)310000(5)
Investment income, nonoperating1100000
Other nonoperating income (expense)1 (0)    
Interest and debt expense     (0)(0)
Loss from continuing operations before income taxes:(23)(27)(35)(38)(39)(30)(26)
Income tax expense(0)(0)(0)(0)(0)  
Loss before gain (loss) on sale of properties:(23)(27)(35)(38)(39)(30)(26)
Other undisclosed net income     00
Net loss available to common stockholders, diluted:(23)(27)(35)(38)(39)(30)(26)

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net loss:(23)(27)(35)(38)(39)(30)(26)
Comprehensive loss:(23)(27)(35)(38)(39)(30)(26)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  0(0)   
Comprehensive loss, net of tax, attributable to parent:(23)(27)(35)(38)(39)(30)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: